Cargando…
Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed to herald a new era in the management of type 2 diabetes (T2D), especially for the many patients with T2D who are at high risk for cardiovascular and renal events. However, as the evidence in favour of variou...
Autores principales: | Schernthaner, Guntram, Shehadeh, Naim, Ametov, Alexander S., Bazarova, Anna V., Ebrahimi, Fahim, Fasching, Peter, Janež, Andrej, Kempler, Péter, Konrāde, Ilze, Lalić, Nebojša M., Mankovsky, Boris, Martinka, Emil, Rahelić, Dario, Serafinceanu, Cristian, Škrha, Jan, Tankova, Tsvetalina, Visockienė, Žydrūnė |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585305/ https://www.ncbi.nlm.nih.gov/pubmed/33097060 http://dx.doi.org/10.1186/s12933-020-01154-w |
Ejemplares similares
-
Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective
por: Hancu, Nicolae, et al.
Publicado: (2021) -
Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)
por: Schernthaner, Guntram, et al.
Publicado: (2017) -
High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study
por: Campbell, Matthew D., et al.
Publicado: (2019) -
SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class
por: Schernthaner, Guntram, et al.
Publicado: (2019) -
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
por: Janež, Andrej, et al.
Publicado: (2020)